METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING ALZHEIMER'S

Details for Australian Patent Application No. 2002306787 (hide)

Owner PANACEA PHARMACEUTICALS, INC. THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND

Inventors GHANBARI, Hossein, A.; MERRIL, Carl, R.

Pub. Number AU-A-2002306787

PCT Number PCT/US02/08619

PCT Pub. Number WO2002/076437

Priority 09/816,289 23.03.01 US

Filing date 22 March 2002

Wipo publication date 8 October 2002

International Classifications

A61K 031/00

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 09/816,289 23.03.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-A-2002306787

6 October 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306788-Stabilization and terminal sterilization of phospholipid formulations

2002306786-Xenograft bone matrix for orthopedic applications